Author

Shantanu Kumar

Translational Health Science and Technology Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Assay:CITE-seq· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Akshita Sinha· 1 shared Amit Kumar SrivastavaiD· 1 shared Asimul IslamiD· 1 shared Bhabatosh DasiD· 1 shared Debaleena Das· 1 shared Deeksha JoshiiD· 1 shared Deepjyoti PauliD· 1 shared Dinesh MahajaniD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Akshita Sinha

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Target-Specific Discovery of BMM_1567 Restores Aminoglycoside Activity Against Multidrug-Resistant Gram-Negative ESKAPE Pathogens

Meenal Chawla, Lekshmi Narendrakumar, Deepjyoti Paul, Ramani Shyam Kapuganti, Shantanu Kumar, Debaleena Das, Kajal Kamboj, Susmita Bakshi, Payal Priyadarshi, Dinesh Mahajan, Shailendra Asthana, Bhabatosh Das

This paper identifies BMM_1567, a peptide that enhances aminoglycoside activity against multidrug-resistant Gram-negative bacteria by inhibiting resistance enzymes.

bioRxiv · Jul 21, 2026 · PreprintMicrobiology

Safe Redosable Low-Immunogenic In Vivo CAR-T Therapy for B Cell Malignancies and Solid Tumors

Raquib Alam, Shantanu Kumar, Rohit Shukla, Nisha Chaudhary, Juli Gupta, Akshita Sinha, Rituparna Chaudhuri, Mohan Ranganathan, Kashif Husain, Nisar Rahim Shaikh, Deeksha Joshi, Jahnvi Hora, Syed Ahmad Ali, Subhankar Bose, Prasad Iyer, , Tanveer Ahmad

This paper develops viroVbot, an in vivo CAR-T platform with reduced immunogenicity and safety, showing efficacy in treating multiple myeloma and gastric cancer through sequential redosing.

bioRxiv · Jul 2, 2026 · PreprintBioengineering